Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BATM Advanced Communications Ltd. (BVC.TA)
Hod HaSharon, IL
BATM Advanced Communications Ltd., alongside its affiliated companies, specializes in the innovation, production, and commercialization of cutting-edge real-time technologies throughout Israel, the United States, and Europe. The enterprise conducts its operations through two distinct divisions: Networking and Cybersecurity, and Bio-Medical. The Networking and Cybersecurity division is responsible for the research, development, manufacturing, and market introduction of various data communication products. These offerings encompass technologies such as network function virtualization, edge computing, carrier ethernet, MPLS access solutions, advanced cyber network monitoring, and robust network encryption. Additionally, this segment delivers a range of software services, including user training, technical support, laboratory assistance, and ongoing maintenance, as well as undertaking construction contracts. Conversely, the Bio-Medical division focuses on delivering molecular biology diagnostic tools and provides comprehensive solutions for managing and neutralizing hazardous pathogenic and medical waste generated in environments like laboratories, hospitals, pharmaceutical production facilities, and agricultural settings. This segment also performs diverse testing services and serves as a distributor for a wide array of diagnostic apparatus and medical consumables from various brands. Established in 1992, BATM Advanced Communications Ltd. maintains its principal corporate office in Hod Hasharon, Israel.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.55% | -6.25% | -6.08% | -12.35% | -34.70% | -20.81% | -35.19% | -50.28% | -86.47% | -42.69% | -42.69% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%+7.3% Q4'25: -1.3% (vs Q4'23)
-
EPS growth Medical - Instruments & Supplies: +16.3%+32.4% ★ Q4'25: -5,650.0% (vs Q4'23)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-8.7% Q4'25: -7.3% (vs Q4'23)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+0.8% Q4'25: +1.4% (vs Q4'23)
-
ROIC Medical - Instruments & Supplies: +6.0%+1.9% Q4'25: +7.0% (vs Q4'23)
-
Share dilution Medical - Instruments & Supplies: +0.1%-0.1% ★ Q4'25: -0.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×1.82× ★ Q4'25: 0.81× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
97.10M
est: 105.24M (-7.7%)
|
90.40M
est: 90.30M (+0.1%)
|
107.14M
est: 104.31M (+2.7%)
|
119.56M
est: 104.14M (+14.8%)
|
123.40M
est: 121.05M (+1.9%)
|
183.57M
est: 179.97M (+2.0%)
|
140.04M
est: 137.81M (+1.6%)
|
116.12M
est: 122.44M (-5.2%)
|
116.73M
est: 132.35M (-11.8%)
|
117.34M
est: 117.00M (+0.3%)
|
125.94M
est: 123.20M (+2.2%)
|
84.30M
84.30M – 84.30M
-31.6% YoY
|
92.72M
92.72M – 92.72M
+10.0% YoY
|
| EBITDA |
2.72M
est: 9.25M (-70.6%)
|
3.11M
est: 7.93M (-60.8%)
|
8.04M
est: 9.16M (-12.3%)
|
5.53M
est: 9.15M (-39.5%)
|
11.20M
est: 10.63M (+5.4%)
|
19.84M
est: 15.81M (+25.5%)
|
31.06M
est: 12.11M (+156.6%)
|
8.12M
est: 10.76M (-24.5%)
|
3.63M
est: 11.63M (-68.8%)
|
972.0K
est: 8.81M (-89.0%)
|
5.72M
est: 9.28M (-38.4%)
|
6.35M
6.35M – 6.35M
-31.6% YoY
|
6.98M
6.98M – 6.98M
+10.0% YoY
|
| EBIT |
-10.88M
est: 5.72M (-290.3%)
|
-266.0K
est: 4.90M (-105.4%)
|
4.31M
est: 5.67M (-23.9%)
|
1.75M
est: 5.66M (-69.1%)
|
5.85M
est: 6.57M (-11.0%)
|
14.37M
est: 9.78M (+47.0%)
|
25.80M
est: 7.48M (+244.7%)
|
3.23M
est: 6.65M (-51.5%)
|
1.79M
est: 7.19M (-75.1%)
|
-4.00M
est: 4.71M (-184.9%)
|
988.5K
est: 4.96M (-80.1%)
|
3.39M
3.39M – 3.39M
-31.6% YoY
|
3.73M
3.73M – 3.73M
+10.0% YoY
|
| Net Income |
-13.25M
est: 435.1K (-3,145.0%)
|
-1.07M
est: 485.1K (-320.6%)
|
233.0K
est: 2.15M (-89.2%)
|
358.0K
est: 1.40M (-74.5%)
|
3.92M
est: 2.48M (+57.8%)
|
9.79M
est: 9.50M (+3.1%)
|
14.34M
est: 13.09M (+9.5%)
|
244.0K
est: 445.9K (-45.3%)
|
-193.0K
est: 1.76M (-111.0%)
|
-22.30M
est: -17.46M (-27.7%)
|
-15.53M
est: -10.92M (-42.3%)
|
154.8K
154.8K – 154.8K
+101.4% YoY
|
2.90M
2.90M – 2.90M
+1,775.0% YoY
|
| SGA |
23.94M
est: 17.02M (+40.7%)
|
23.89M
est: 14.61M (+63.6%)
|
25.28M
est: 16.87M (+49.9%)
|
26.86M
est: 16.85M (+59.5%)
|
28.06M
est: 19.58M (+43.3%)
|
36.08M
est: 29.11M (+23.9%)
|
30.53M
est: 22.29M (+37.0%)
|
30.23M
est: 19.81M (+52.6%)
|
8.09M
est: 21.41M (-62.2%)
|
7.58M
est: 20.79M (-63.5%)
|
34.81M
est: 21.90M (+59.0%)
|
14.98M
14.98M – 14.98M
-31.6% YoY
|
16.48M
16.48M – 16.48M
+10.0% YoY
|
| EPS |
-0.03
est: 0.00 (-3,404.3%)
|
0.00
est: 0.00 (-343.3%)
|
0.00
est: 0.00 (-87.8%)
|
0.00
est: 0.00 (-72.0%)
|
0.01
est: 0.01 (+63.7%)
|
0.02
est: 0.02 (+2.1%)
|
0.03
est: 0.03 (+8.8%)
|
0.00
est: 0.00 (-41.2%)
|
0.00
est: 0.00 (-109.9%)
|
-0.05
est: -0.04 (-27.5%)
|
-0.03
est: -0.03 (-38.0%)
|
0.00
0.00 – 0.00
+101.4% YoY
|
0.01
0.01 – 0.01
+1,775.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Moti Nagar | Chief Executive Officer & Executive Director | 677.0K | male |
| Leor Miles | Chief Financial Officer & Executive Director | 303.0K | male |
| Haim Schwartz | Chief Operating Officer | — | male |
| Yair Livneh | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BVC.TA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
